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syndrome
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Daryl A. Scott3,31, Ziva Ben-Neriah13, Vardiella Meiner13, Hanoch Cassuto28, Orly Elpeleg29, J. Lloyd Holder Jr14,
Lindsay C. Burrage3, Laurie H. Seaver15, Lionel Van Maldergem16, Sonal Mahida17, Janet S. Soul17,
Margaret Marlatt17, Ludmila Matyakhina18, Julie Vogt19, June-Anne Gold20, Soo-Mi Park20, Vinod Varghese21,
Anne K. Lampe22, Ajith Kumar23, Melissa Lees23, Muriel Holder-Espinasse24, Vivienne McConnell2, Birgitta Bernhard6,
Ed Blair25, Victoria Harrison26, The DDD study27, Donna M. Muzny3,7, Richard A. Gibbs3,7, Sarah H. Elsea1,3,
Jennifer E. Posey3, Weimin Bi1,3, Seema Lalani1,3,14, Fan Xia1,3, Yaping Yang1,3, Christine M. Eng1,3,
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Correction to: Genome Med (2019) 11:12
https://doi.org/10.1186/s13073-019-0623-0
It was highlighted that the original article [1] contained
a typographical error in the Results section. Subject 17
was incorrectly cited as Subject 1. This Correction article
shows the revised statement. The original article has been
updated.
Correct statement:
“Of note, subject 17 of our cohort presented with mild
delayed motor milestones, generalized hypotonia, and, in
particular, dysmorphic features including midface hypo-
plasia, tented upper lips, along with sleep issues, ASD,
food-seeking behavior, and aggressive behavior; these
clinical features are similar to those reported in SMS.”
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